As the M.D. Anderson fiasco illustrates, IBM fell into the trap of over-promising and under-delivering. “IBM claimed in 2013 that ‘a new era of computing has emerged’ and gave Forbes the impression that Watson ‘now tackles clinical trials’ and would be in use with patients in just a matter of months,” Freedman noted.
.
.
.
Instead, IBM is ceding whatever AI leadership it purported to have to a new crop of far more innovative startups and other AI firms willing to reinvent themselves as the inexorable pace of innovation continues unabated – and that’s no joke.
https://www.forbes.com/sites/jasonbloomberg/2017/07/02/is-ibm-watson-a-joke/#3454d690da20